Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-03-07
2006-03-07
Brumback, Brenda (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S399000
Reexamination Certificate
active
07008924
ABSTRACT:
The present invention provides novel VGF polypeptides and selective binding agents. The invention also provides host cells and methods for producing VGF polypeptides. The invention further provides VGF pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, conditions, and disorders associated with VGF polypeptides.
REFERENCES:
Possenti et al. EMBO J. 8: 2217-2223, 1989.
Salton J. Neurochem. 57: 991-996, 1991.
Rudinger, In, “Peptide Hormones” (Ed. J.A. Parsons) University Park Press, Baltimore, pp. 1-7, 1975.
Canu et al., “Cloning, structural organization analysis, and chromosomal assignment of the human gene for the neurosecretory protein VGF.”Genomics15:443-6 (1997).
Schwartz et al., “Hypothalamic response to starvation: implications for the study of wasting disorders.”Am J Physiol269:949-57 (1995).
Hahm et al., “Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance.”Neuron23:537-48 (1999).
Liu et al., “Peptide V: a VGF-derived neuropeptide purified from bovine posterior pituitary.”Endocrinology135:2742-8 (1994).
Trani et al., “Tissue-specific processing of the neuroendocrine protein VGF.”J Neurochem65:2441-9 (1995).
Miyatake et al., “The signal transduction pathway for VGF expression due to NGF is different from that due to bFGF in PC12h cell.”Biochem Mol Biol Int30:231-6 (1993).
Altshuler and Hirschhorn. “Upsetting the Balance: VGF and the Regulation of Body Weight.”Neuron. 23:415-417 (1999).
Boone Thomas Charles
Yan Hai
Amgen Inc.
Brumback Brenda
Hayes Robert C.
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
VGF fusion polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VGF fusion polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VGF fusion polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595668